Xiao‐Feng He
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Obstetrics and Gynecology top 10%
Papers in
-
- Glutathione Transferases and Polymorphisms 15
- DNA Repair Mechanisms 10
- RNA modifications and cancer 6
- Co-authors
- Jiao Su (18 shared papers)Dapeng Ding (9 shared papers)Xianghua Ye (8 shared papers)Xuliang Shen (6 shared papers)Yuanhao Liang (8 shared papers)Ying Zhang (2 shared papers)Ying Zhang (3 shared papers)Zhizhong Liu (6 shared papers)
- Journals
- PLoS ONE (10 papers)Frontiers in Genetics (8 papers)Medicine (7 papers)Molecular Biology Reports (4 papers)Bioscience Reports (4 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Xiao‐Feng He
93 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 89
- Hepatology 103
- Obstetrics and Gynecology 74
- Cancer Research 141
- Oncology 190
- Molecular Biology 426
Countries citing papers authored by Xiao‐Feng He
This map shows the geographic impact of Xiao‐Feng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng He more than expected).
Fields of papers citing papers by Xiao‐Feng He
This network shows the impact of papers produced by Xiao‐Feng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng He. The network helps show where Xiao‐Feng He may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao‐Feng He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 79 | |
| 2 | 2020 | 56 | |
| 3 | 2015 | 40 | |
| 4 | 2011 | 35 | |
| 5 | A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma. | 2007 | 32 |
| 6 | 2013 | 31 | |
| 7 | Combination of Transarterial Chemoembolization (TACE) and Radiofrequency Ablation (RFA) vs. Surgical Resection (SR) on Survival Outcome of Early Hepatocellular Carcinoma: A Meta-Analysis. | 2015 | 31 |
| 8 | 2013 | 30 | |
| 9 | 2014 | 29 | |
| 10 | 2019 | 27 | |
| 11 | 2011 | 27 | |
| 12 | 2011 | 25 | |
| 13 | 2022 | 24 | |
| 14 | 2011 | 24 | |
| 15 | 2013 | 24 | |
| 16 | 2024 | 23 | |
| 17 | 2012 | 23 | |
| 18 | 2012 | 22 | |
| 19 | 2013 | 22 | |
| 20 | 2014 | 22 |
About Xiao‐Feng He
Xiao‐Feng He is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 97 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (15 papers), DNA Repair Mechanisms (10 papers), BRCA gene mutations in cancer (7 papers), Folate and B Vitamins Research (6 papers), RNA modifications and cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Hepatology (103 citations), Obstetrics and Gynecology (74 citations), Cancer Research (141 citations), Oncology (190 citations) and Molecular Biology (426 citations). Xiao‐Feng He has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Jiao Su, Dapeng Ding, Xianghua Ye, Xuliang Shen, Yuanhao Liang, Ying Zhang, Ying Zhang, Zhizhong Liu, Jie Zhang and Yanhao Li. Their work appears in journals such as PLoS ONE, Frontiers in Genetics, Medicine, Molecular Biology Reports and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.